Food Science and Biotechnology

Korean Society of Food Science and Technology (한국식품과학회)
권호 표지

Effect of Ethanol Extract of Safflower Seed on Bone Loss in Ovariectomized Rat

  • Cho, Sung-Hee (Department of Food Science and Nutrition, Catholic University of Daegu) ;
  • Choi, Sang-Won (Department of Food Science and Nutrition, Catholic University of Daegu) ;
  • Choi, Young-Sun (Department of Food and Nutrition, Daegu University) ;
  • Kim, Hee-Jung (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Park, Youn-Hee (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Bae, Yong-Chul (Department of Anatomy, School of Dental Medicine, Kyungpook National University) ;
  • Lee, Won-Jung (Department of Physiology, School of Medicine, Kyungpook National University)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

We investigated whether ethanol extracts of the safflower seeds containing phenolic compounds were responsible for the bone-protecting effects. Crude ethanol extract (CEE) of the safflower seeds was fed for 4 weeks at the level of 1% in diet to female Sprague-Dawley rats that had been subjected to bilateral ovariectomy (OVX). The CEE effects (OVX+CEE) were evaluated by comparing results obtained from OVX, Sham, and OVX injected with $17{\beta}$-estradiol ($OVX+E_2$) groups. OVX resulted in a dramatic reduction in the trabecular bone mass of the proximal tibia (approximately 40% of the Sham group) and an increase in fat deposition in bone marrow. In $OVX+E_2$ group, the bone loss was completely prevented as well as marrow adiposity. In OVX+CEE group, approximately 80% of the bone mass was maintained compared with Sham group and fat deposition in the bone marrow was prevented. Meanwhile, the partially purified ethanol extract containing the phenolic compounds stimulated proliferation of the ROS 17/2.8 osteoblast-like cells in a dose-dependent manner, as potently as positive controls of $E_2$ and genistein. The present data demonstrate that the ethanol extracts of safflower seeds reduced bone loss caused by estrogen deficiency. The bone-protecting effect of safflower seeds seems to be mediated, at least partly, by the stimulating effect of the phenolic compounds on the growth of osteoblasts.

Keywords

References

  1. Eskin BA, Traen BR. The Geripause: Medical Management during the Late Menopause. 1st ed. Parthenon Publishing, Lancashire, UK. pp. 17-30 (2003)
  2. Michaelsson K, Baron JA, Farahmand BY, Johnell O, Magnesson C, Persson PG, Persson I, Ljunghall S. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish hip fracture study group. Brit. Med. J. 316: 1858-1863 (1998) https://doi.org/10.1136/bmj.316.7148.1858
  3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288: 321-333 (2002) https://doi.org/10.1001/jama.288.3.321
  4. Cahnson P. Historical perspective of hormone replacement therapy Rev. Pratician 55: 369-375 (2005)
  5. Morello KC, Wurz GT, DeGregorio MW. SERMs: Current status and future trends. Crit. Rev. Oncol. Hemat. 43: 63-76 (2002) https://doi.org/10.1016/S1040-8428(02)00022-7
  6. Labrie F. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Endocr. Relat. Cancer 13: 335-355 (2006) https://doi.org/10.1677/erc.1.00883
  7. Vogelvang TE, van der Mooren MJ, Mijatovic V. Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications. Treat Endocrinol. 3: 105-115 (2004) https://doi.org/10.2165/00024677-200403020-00005
  8. Bolego C, Vegeto E, Pinna C, Maggi A, Cignarella A. Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Arterioscl. Thromb. Vas. 26: 2192-2199 (2006) https://doi.org/10.1161/01.ATV.0000242186.93243.25
  9. Francucci CM, Romagni P, Boscaro M. Raloxifene: bone and cardiovascular effects. J. Endocrinol. Invest. 28: 85-89 (2005)
  10. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 65: 995-1016 (2004) https://doi.org/10.1016/j.phytochem.2004.03.005
  11. Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. Eur. J. Clin. Nutr. 52: 850-855 (1998) https://doi.org/10.1038/sj.ejcn.1600659
  12. Adlercreut H, Mazur W, Stumpf K, Kilkkinen A, Pietinen P, Hulten K, Hallmans G. Food containing phytoestrogens, and breast cancer. Biofactors 12: 89-93 (2000) https://doi.org/10.1002/biof.5520120114
  13. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87: 897-904 (1996)
  14. Draper CR, Edel MJ, Dick LM, Randall AG, Martin GB, Prince RL. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr, 127: 1795-1799 (1997)
  15. Anderson JB, Garner SC. The effects of phytoestrogens on bone. Nutr, Res. 17: 1617-1632 (1997) https://doi.org/10.1016/S0271-5317(97)00156-5
  16. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126: 161-167 (1996) https://doi.org/10.1093/jn/126.1.161
  17. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC. Bonesparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am. J. Clin. Nutr. 68: 1364S-1368S (1998)
  18. Alekel L, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 72: 844-852 (2000) https://doi.org/10.1093/ajcn/72.3.844
  19. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68: 1375S-1379S (1998)
  20. Huang HY, Yang HP, Yang HT, Yang TC, Shieh MJ, Huang SY. One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect. J. Nutr. Biochem. 7: 509-517 (2006)
  21. Kim JH, Jeon SM, An MY, Ku SK, Lee IH, Choi MS, Moon KD. Effects of diet of Korean safflower (Carthamus tinctorius L.) seed powder on bone tissue in rats during the recovery of rib fracture. J. Korean Soc. Food Sci. Nutr. 27: 698-704 (1998)
  22. Chung SY, Choi HJ, Chung MW, Ahn MR, Yoo TM, Rheu HM, Ang JS. Effects of safflower seed on the fracture healing in rat tibia. Yakhak Hoeji 43: 526-534 (1999)
  23. Chung SY, Choi HJ, Chung MW, Ahn MR, Yoo TM, Rheu HM, Yang JS. Effects of safflower seed on the fracture healing in rat tibia. Arch. Pharm. Res. 25: 313-317 (2002) https://doi.org/10.1007/BF02976632
  24. Seo HJ, Kim JH, Kwak DY, Jeon SM. The effects of safflower seed powder and its fraction on bone tissue in rib-fractured rats during the recovery. Korean J. Nutr. 33: 411-420 (2000)
  25. Yun IH, Cho KJ, Kim DS, Woo HK, Chang RD. Effects of safflower extracts on activation of calcium channel, proliferation of osteoblast, and bone density of osteoporotic patients. Final Report of Agricultural and Fishery Project, Department of Oral Anatomy, School of Dentistry, Pusan National University, Busan, Korea (2002)
  26. Bae SJ, Shim SM, Park YJ, Lee JY, Chang EJ, Choi SW. Cytotoxicity of phenolic compounds isolated from seeds of safflower (Carthamus tinctorius L.) on cancer cell lines. Food Sci. Biotechnol. 11: 140-146 (2002)
  27. Kim EO, Oh JH, Lee SK, Lee JY, Choi SW. Antioxidant properties and quantification of phenolic compounds from safflower (Carthamus tinctorius L.) seeds. Food Sci. Biotechnol. 16: 71-77 (2007)
  28. Kim HJ, Bae YC, Park RW, Choi SW, Cho SH, Lee WJ. Bone-protecting effect of safflower seeds in ovariectomized rats. Calc. Tiss. Int. 71: 88-94 (2002) https://doi.org/10.1007/s00223-001-1080-4
  29. The American Institute of Nutrition: Report of the American Institute of Nutrition Ad Hoc Committee on standards for nutritional studies. J. Nutr. 107: 1340-1348 (1977) https://doi.org/10.1093/jn/107.7.1340
  30. Mosmann TJ. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol. Methods 65: 55-63 (1983) https://doi.org/10.1016/0022-1759(83)90303-4
  31. Ramirez ME, McMurry MP, Wiebke GA, Felton KJ, Ren K, Meikle AW, Iverius PH. Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism 46: 179-185 (1997) https://doi.org/10.1016/S0026-0495(97)90299-7
  32. Valette A, Meignen KM, Mercier L, Liehr JG, Boyer J. Effects of 2-fluoroestradiol on lipid metabolism in the ovariectomized rat. J. Steroid Biochem. 25: 575-578 (1986) https://doi.org/10.1016/0022-4731(86)90405-X
  33. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 27: 31-40 (1997) https://doi.org/10.1080/01635589709514498
  34. Wronski TJ, Walsh CC, Ignaszewskin LA. Histologic evidence for osteopenia and increased bone turn over in ovariectomized rats. Bone 7: 119-123 (1986) https://doi.org/10.1016/8756-3282(86)90683-6
  35. Martin RB, Chow BD, Lucas PA. Bone marrow fat content in relation to bone remodeling and serum chemistry in intact and ovariectomized dogs. Calc. Tiss. Int. 46: 189-194 (1990) https://doi.org/10.1007/BF02555043
  36. Wang GW, Sweet D, Reger S, Thompson R. Fat cell changes as a mechanism of avascular necrosis in the femoral head in cortisone-treated rabbits. J. Bone Joint Surg. Am. 59A: 729-735 (1977)
  37. Minaire P, Meunier PJ, Edouard C, Bernard J, Coupron J, Bouret J. Quantitative histological data on disuse osteoporosis. Calc. Tiss. Res. 17: 57-73 (1974) https://doi.org/10.1007/BF02547214
  38. Nuttall ME, Patton AJ, Oliverta DL, Nadeau PD, Gowen ME. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J. Bone Miner. Res. 13: 371-382 (1998) https://doi.org/10.1359/jbmr.1998.13.3.371
  39. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell culture. J. Cell Sci. 102: 341-351 (1992)
  40. Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Mowik CW. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J. Bone Miner. Res. 17: 394-405 (2002) https://doi.org/10.1359/jbmr.2002.17.3.394
  41. Robinson JA, Harris SA, Riggs BL, Spelsberg TC. Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138: 2919-2927 (1997) https://doi.org/10.1210/en.138.7.2919
  42. Sugimoto E, Yamguchi M. Anabolic effect of genistein in osteoblstic MC3T3-E1 cells. Int. J. Mol. Med. 5: 515-520 (2000)
  43. Thompson LU, Orcheson L, Rickard S, Jenab M, Serraino M, Seidl M, Cheung F. Anticancer effects of flaxseed lignans. pp. 356-364. In: Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention. Kumpulainen JT, Salonen JT (eds). The Royal Society of Chemistry, Cambridge, UK (1996)
  44. Ward WE, Yuan YV, Cheung AM, Thompson, LU. Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Brit. J. Nutr. 86: 499-505 (2001) https://doi.org/10.1079/BJN2001429
  45. Gustafsson BI, Westbroek I, Waarsing JH, Waldum H, Solligard E, Bnmsvik A, Dimmen S, van Leeuwen JP, Weinans H, Syversen U. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J. Cell. Biochem. 97: 1283-1291 (2006) https://doi.org/10.1002/jcb.20733
  46. Wronski TJ, Walsh CC, Ignaszewskin LA. Histologic evidence for osteopenia and increased bone tum over in ovariectomized rats. Bone 7: 119-123 (1986) https://doi.org/10.1016/8756-3282(86)90683-6
  47. Taranta A, Brama M, Teti A, Luca VD, Scandurra R, Spera R, Spera G, Agnusdei D, Termine JD, Migliaccio S. The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro. Bone 30: 368-376 (2002) https://doi.org/10.1016/S8756-3282(01)00685-8
  48. Tsutsumi N. Effect of coumestrol on bone metabolism in organ culture. Biol. Pharm. Bull. 18: 1012-1015 (1995) https://doi.org/10.1248/bpb.18.1012
  49. Hagiwara H, Naruse M, Adachi C, Inoue A, Hiruma Y, Otsuka E, Naruse K, Demura H, Hirose S. Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calcarial osteoblast-like cells. J. Biochem. -Tokyo 126: 168-173 (1999) https://doi.org/10.1093/oxfordjournals.jbchem.a022418